Pan-India multidisciplinary program aims to improve coordinated care for patients with chronic kidney disease and heart failure
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process
The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
The medical-grade Angelas diode laser calibrated at a 1470 nm wavelength supports microsurgeries across multiple specialties
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Initiatives include scholarships, STEM initiatives, and healthcare capacity-building programmes supporting women and girls across 52 countries
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
Women’s wellness initiative promoted preventive healthcare, fitness, and self-care awareness across the Mira Bhayandar community
Subscribe To Our Newsletter & Stay Updated
